Testing effectiveness (Phase 2)Study completedNCT00930163
What this trial is testing
Lebrikizumab (MILR1444A) in Adult Patients With Asthma Who Are Inadequately Controlled on Inhaled Corticosteroids
Who this might be right for
Asthma
Genentech, Inc. 218